SOAT1 and amyotrophic lateral sclerosis: Together, these results demonstrate that primary NK cells are already stimulated in the peripheral blood of control and ALS participants, but tofacitinib can nevertheless suppress primary NK cell cytotoxicity by inhibiting JAK/STAT signaling.